FDA Inspection 1014489 — Holy Cross of Silver Spring Blood Bank

Holy Cross of Silver Spring Blood Bank — FEI 1173166

The FDA completed an inspection of Holy Cross of Silver Spring Blood Bank on May 25, 2017 in Silver Spring, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 25, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Silver Spring, MD (United States)